AcquisitionsMay 11, 2026, 04:21 PM
Hims & Hers to Acquire Eucalyptus for up to $1.15B; Reports Q1 Net Loss
AI Summary
Hims & Hers Health, Inc. announced its Q1 2026 financial results, reporting a net loss of $92.1 million, a significant shift from a net income of $49.5 million in Q1 2025. This quarter included a major strategic move to acquire Eucalyptus, an Australia-based digital health company, for up to $1.15 billion, aiming to expand its international presence. The company also incurred $33.5 million in restructuring charges related to a strategic shift in its US weight loss offering. Revenue increased to $608.1 million, up from $586.0 million year-over-year.
Key Highlights
- Hims & Hers to acquire Eucalyptus for up to $1.15 billion.
- Q1 2026 net loss of $(92.1) million, compared to $49.5 million net income in Q1 2025.
- Q1 2026 basic EPS of $(0.40), down from $0.22 in Q1 2025.
- Q1 2026 revenue increased to $608.1 million, up from $586.0 million in Q1 2025.
- Incurred $33.5 million in restructuring charges for US weight loss offering.
- US revenue was $529.9 million; Rest of the World revenue was $78.2 million.
- Net cash provided by operating activities was $89.4 million in Q1 2026.